Perception of adverse events in adults over 60 years old after receiving the vaccine against covid19. Corrientes. 2021
Objective:To describe adverse eventsperceivedbyadultsover 60 years of ageafterreceivingthefirstdose of thevaccineagainst COVID19 in Corrientes Capital during 2021. Methodology: Observational, descriptive, cross-sectionalstudy. Non-probabilisticsamplingforco nvenience. Adultpopulationover 6...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Sanatorio Allende. Departamento de enfermería
2022
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/notasenf/article/view/38016 |
| Aporte de: |
| Sumario: | Objective:To describe adverse eventsperceivedbyadultsover 60 years of ageafterreceivingthefirstdose of thevaccineagainst COVID19 in Corrientes Capital during 2021. Methodology: Observational, descriptive, cross-sectionalstudy. Non-probabilisticsamplingforco nvenience. Adultpopulationover 60 years of ageimmunizedagainst COVID19. Variables:age, gender, currentoccupation, perception of adverse events, time of appearance, knowledge of adverse events, local perception of pain, inflammation, erythema, pruritus; at thesystemiclevel of fever, headache, drowsiness, dizziness, dyspnea, cough, chills, myalgia, asthenia, arthralgia; digestivedyspepsia, loss of appetite, nausea. Self-preparedsurveywithanonymousinformed consent, validatedthrough a pilot test, appliedto a fraction of the target population, whichallowedadjustments and improvementsto be madebeforefinallyapplyingittothesample. Analyzedwith Microsoft Excel and Epidat 4.1. Results:Populationstudied: 90 adultsover 60 years of age, 39 presented adverse events, 59% women. Agerange 60-87 years, average 72 years. Occupation of adultswhopresentedevents: 51% retired, 31% independentworkers, 18% workers in a dependencyrelationship. Appearance time: 87% in thefirst 24 hours, 13% between 24 and 48 hours. 97% wereaware of adverse events. Accordingtothetype of adverse eventperceived, 77.9% reported local events, 48.7% systemic, 10.2% digestive. In local adverse events, 100% presentedpain; simultaneousmanifestations, 87%, 13% twoor more. Of systemic adverse events, 79% myalgia, 63% fever, 63% asthenia, 63% arthralgia, 47% headache, 42% chills, 31% cough, 26% dizziness, 21% dyspnea, 16% drowsiness; in number of simultaneousmanifestations 16% two, 21% three, 26% four, 37% fiveor more. Digestiveevents: 100% loss of appetite, 75%nausea, 25% dyspepsia; simultaneousmanifestations, 25% one, 50% two, 25% three. Conclusion:Theolderadultswhoperceived adverse eventswereslightly more frequentlywomen. Themostreportedwere local, followedbysystemic and lessfrequently at thedigestivelevel. |
|---|